PRE AND POST PLASMID CURING EFFECT ON PSEUDOMONAS AERUGINOSA SUSCEPTIBILITY TO ANTIBIOTICS by Orhue, Philip Ogbeide et al.
  
 
Ivy Union Publishing | http: //www.ivyunion.org         ISSN 2572-5815         December 4, 2017 | Volume 5 | Issue 1  
 
Orhue PO et al. American Journals of Current Microbiology 2017, 5:33-41                                  Page 1 of 9 
 
7 
6  
 
Pre and Post Plasmid Curing Effect on Pseudomonas 
Aeruginosa Susceptibility to Antibiotics 
 
Philips Ogbeide Orhue
 1
*, Faith Oseahumen Okoebor
 2
, 
and McSionel Abdul-Razaq Momoh
 3
 
 
1 
Department of Medical Laboratory Sciences, Ambrose Alli University, Ekpoma, Nigeria. 
2 
Department of Microbiology, Ambrose Alli University, Ekpoma, Nigeria 
3 
Department of Medical Microbiology, Ambrose Alli University, Ekpoma, Nigeria
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Research Article 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: Pseudomonas aeruginosa; antibiotics susceptibility; plasmid curing; clinical isolates 
Received: September 12, 2017; Accepted: October 19, 2017; Published: December 5, 2017 
Competing Interests: The authors have declared that no competing interests exist. 
Copyright: 2017 Orhue PO et al. This is an open-access article distributed under the terms of the 
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction 
in any medium, provided the original author and source are credited. 
*Correspondence to: ORHUE Ogbeide Philips, Department of Medical Laboratory Sciences, 
Ambrose Alli University, Ekpoma, Nigeria 
Email: orhue_philips@yahoo.com 
 
Abstract: This study investigates the effect of plasmid curing on antibiotics susceptibility pattern of 
Pseudomonas aeruginosa clinical isolates. The study involved confirmed clinical samples of P. 
aeruginosa obtained from patients attending the general out-patient department of Irrua Specialist 
Teaching Hospital, Irrua-Nigeria. Samples with established Pseudomonas aeruginosa were subjected to 
antibiotic susceptibility testing before plasmid curing (group 1) and after plasmid curing (group 2) using 
Sodium Dodecyl Sulfate intercalating dye following previously determined standard procedures. 
Antibiotic resistivity and susceptibility outcomes were then determined by measuring the zone of 
inhibition and the pre and post cured experiments were compared. The results showed that Pseudomonas 
aeruginosa is 100% resistance to tetracycline, cefotaxime, ethromycin, methronidazole, nitrofuratoin, 
ampicillin-clauvulanate, ampicillin, amoxicillin and ampiclox. Post-plasmid curing resulted to increased 
susceptibility rangeing from 13.3% to 92.0% as against 5.3% to 80% in the pre-plasmid cured P. 
aeruginosa. Based on these findings, clinical isolates of P. aeruginosa in the study area has a very high 
resistance rate that may be due to plasmid development or mutation of the organism and thus, the call for 
clinicians to carryout antibiotics susceptibility testing prior to antibiotic prescription. 
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1. Introduction 
Many years ago, Pseudomonas aeruginosa (P. aeruginosa) was rarely considered as a real pathogen, 
it was however recognized as the microorganism associated with bacteraemia in the neutropenic host 
in the 1970s. Nowadays, P. aeruginosa is the most common Gram negative opportunistic pathogen 
found in nosocomial infections and causing various spectra of infections especially in neutropenic, 
immune-compromised burns / tissue injury and cystic fibrosis patients all over the world [1, 2]. 
There has been increasing incidence of infections caused by multi-drug resistant organisms 
and has caused attention to be focused on measures of fighting resistance, foremost of which is 
susceptibility surveillance [3, 4]. When strains have multiple antibiotic resistance, the choice of 
therapy is limited, thus the tremendous therapeutic advantages afforded by the introduction of new 
antimicrobial agents will always be threatened by the emergence of increasingly resistant bacteria 
pathogen [5, 6]. Worrisome, antibiotic resistance P. aeruginosa has becomes a contributing factor to 
the re-emergence of diseases which were well-controlled before now. P. aeruginosa is intrinsically 
resistant to many structurally similar antimicrobial agents due to the low permeability of its outer 
membrane (1/100 of the permeability of E. coli outer membrane) [7], the constitutive expression of 
various efflux pumps with wide substrate specificity [8], and the naturally occurring chromosomal 
AmpC β-lactamase [9]. 
However, it has been reported that many antibiotic resistance genes reside in transmissible 
plasmids which facilitate their transfer [10]. According to Govan et al [11], plasmid-mediated 
resistance involving modifying enzymes is particularly associated with topical antibiotic use and with 
sites where high levels of antibiotics are achieved. The term plasmid was first introduced in 1952 by 
the American Molecular biologist, Joshua Lederberg [12]. Plasmids are covalently closed, circular, 
double stranded and self-replicating DNA molecule that carries few gene and are autonomous 
molecule that exist in cell as extra chromosomal genome. Some plasmids can be inserted into a 
bacterial chromosome, where they become a permanent part of the bacterial genome. They vary in 
size from a few genes to several hundred with the smallest plasmids contain the information necessary 
for replication and the larger ones code for more functions such as antibiotic resistance. Curing of 
plasmids is a process by which the bacterial cells lose their plasmids during cell division, these types 
of cells are said to be cured. Curing may occur naturally through cell division or by treating the cells 
with chemical and physical agents [13]. 
There has been accumulating evidence of altered resistance capacity in P. aeruginosa strains 
[14-16] and this could be due to loss of its resistant plasmid. Plasmid mediated resistance to various 
antimicrobial drugs has been demonstrated [17, 18]. In a study at Lagos University Teaching Hospital, 
Nigeria, resistance to gentamicin, tobramycin and carbenicillin were attributed to transferable 
plasmids [19]. However, the isolation and characterisation of plasmids and the occurrence and 
detection of AmpC L-lactamases in P. aeruginosa have been noted. This process entails the isolation 
of plasmids from the multidrug-resistant isolates, demonstrating plasmid mediated resistance by 
plasmid-curing and transformation experiments. This study was therefore undertaken to compare the 
antibiotics susceptibility pattern following pre-cured and post-cured plasmid bearing isolate of P. 
aeruginosa strains from clinical specimens. 
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2. Materials and Methods 
2.1 Materials / Equipment 
The materials and equipment used in this study includes; Bijoux bottles, test tubes, measuring cylinder, 
petri dishes, conical flask, weighing balance, bunsen burner, aluminiun foil, innoculating wire loop, 
pasteaur pipette, spatula, test tubes rack, cotton wool, autoclave, sterile distilled water, disinfectant, 
hot air oven and incubator. 
2.2 Media 
The media used comprised of Muller-Hinton agar, Nutrient agar and peptone water. Media were 
prepared according to manufacturer’s guide. 
2.3 Samples 
The sample study population included all patients attending the general out-patient department of 
Irrua Specialist Teaching Hospital (ISTH) Irrua. However, only subjects with confirmed P. aeruginosa 
infections formed the test population. Samples were collected, stored and processed using standard 
laboratory procedures. 
The research was conducted in the Medical Microbiology Laboratory of Ambrose Alli 
University, Ekpoma. Over the study period, a total of seventy five P. aeruginosa isolates (comprising 
of 33 female and 42 male subjects) from one hundred and fourty three (143) clinical specimens were 
identified and examined by standard bacteriological methods (Colonial morphology, citrate test, 
oxidase test, indole test) and growth at 420C. The isolates were recovered from urine, urethral swab 
aspirate, wound swab, ear swab and high viginal swab (HVS). 
2.4 Sterilization of Equipment Used 
Wire loops were sterilized by passing them through a Burnsen burner flame until it was red hot before 
use. While all glass wares were washed with detergent, rinsed in distilled water and sterilized at 1600C 
in the hot air oven for 1 hour before use. 
2.5 Identification of Isolates 
Morphorlogical characteristics and biochemical tests were used to identify isolates. 
2.6 Plasmid curing experiment 
The curing of plasmid DNA content in P. aeruginosa isolates was carried out according to Lexmi et al. 
[20] and Winker et al. [21]. The curing agent used was Sodium Dodecyl Sulfate (SDS).-a DNA 
intercalating dye. In the experimental process, resistance plasmid DNA of multidrug resistant strain 
was cured by inoculating 10ml of nutrient broth with the test isolates and incubated for 3-4 hours to 
allow minimal growth of the organism. One millilitre of 10% SDS (curing agent) was added and this 
brought the concentration to 1% [w/v] SDS. It was then incubated for 24-48 hours at 370C, thereafter, 
the antibiotic susceptibility of the cured isolates were determined as previously described. 
2.7 Antibiotic susceptibility testing 
In vitro antibiotic sensitivity of strains before curing, where determined by Kirby- Baur disc diffusion 
technique, and as previously described by Daini and Adesemowo [22], and standardized by the 
method of National Committee for Clinical Laboratory Standards [23]. The following antibiotic Gram 
negative muti discs were used: Ampicillin, Amoxcilln, Ampiclox, Fluzapen, Unasyn, 
Ampicillin-clauvulanate, Gentamycin, Tobramycyn, Streptomycin, Chloramphenicol, Tetracycline, 
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Cotrimoxazole, Methronidazole, Nitrofurantoin, Erythromycin, Ofloxacin, Ciprofloxacin, Pefloxacin, 
Ceftriazone, Cefotaxime and Cefuroxime. 
The nutrient agar and Muller Hinton agar used for the sensitivity test of the isolate pre and 
post plasmid curing, were prepared according to the manufacturer’s instruction. Overnight broth 
cultures of the test isolate adjusted to 105cfu/ml were plated by aseptically spreading unto Muller 
–Hinton agar plates. Commercially available Gram negative antibiotic sensitivity disc were placed 
aseptically on the inoculated nutrient medium with the aid of a sterile forcep. The plates were 
incubated at 370C for 24hours [24]. The zone of inhibition was measured and recorded in mm in 
accordance to the NCCLS Criteria [23]. 
2.8 Data Analysis 
Data were analysed using the Statistical Package for Socio Sciences (version 17) and where 
applicable the simple descriptive statistics was carried out. Results were then presented in suitable 
tables and charts for summarization and simplicity. 
3. Results 
A total of seventy-five P. aeruginosa positive clinical samples from attendees of the out patients 
department of the Irrua Specialist teaching hospital were used for this study. Table 1 shows the 
distribution of these samples by age and sex. Samples from male accounted for 44.0% while female 
samples accounted for 56.0%. Most samples were derived from patients within the age range of  
20-39 years (36; 48.0%) and the least from patients between 40-59 years (5; 6.7%). Patients less than 
19 years and those above 60 years contributed 14.7% and 30.7% of the total samples. 
 
Table 1 Age and sex distribution of the Pseudomonas aeruginosa isolates 
S.NO            Age Groups (Years) Males 
(n=33; 44.0%) 
Female 
(n=42; 56.0%) 
Total 
(N=75; 100%) 
1       0-19 5 (6.7) 6 (8) 11 (14.7) 
2    20-39 15(20) 21 (28) 36 (48.0) 
3    40-59 3(4) 2(2.7) 5 (6.7) 
4       >60 10(13.3) 13(17.3) 23 (30.7) 
N  33(44%) 42(56%) 75(100) 
Figure 1 presents the sources of the clinical samples from which P. aeruginosa were isolated. Urine (46.6%) and 
wound swab (33.3%) samples were the major sources for recovering P. aeruginosa. Samples were also recovered 
from ear swab (n = 6; 8%), aspirate (n = 4; 5.3%), high viginal swab (n = 3; 4%) and urethral swab (n = 2; 2.7%). 
 
 
 
 
      
Figure 1. Distribution of Pseudomonas 
aeruginosa sources isolated from 
clinical specimens 
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Table 2  Pre and post plasmid curing antibiotic susceptibility pattern of Pseudomonas aeruginosa isolates 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 presents the antibiotic resistivity and susceptibility pattern of P. aeruginosa pre and 
post plasmid curing. P. aeruginosa showed increase susceptibility post-plasmid curing in all the 
antibiotics herein investigated except for the Ampicillin, Ampicillin-clauvulanate, Nitrofuratoin and 
Ethromycin where there were 100% resistivity pre and post-plasmid curing. Comparatively, penicilins 
that had a 100% resistance to it by P. aeruginosa pre plasmid curing, subsequently, showed 
susceptibilities ranging from 13.3% to 16.0% post plasmid curing. Prior to plasmid curing, the 
B-lactames antibiotics showed susceptibilities ranging from 16.0% to 21.3% but their susceptibilities 
range from 26.7% to 54.7% post plasmid curing. The aminoglycosides antibiotics were susceptible to P. 
aeruginosa pre-plasmid curing (38.7% t0 53.3%) and post-plasmid curing (50.7% to 86.7%). For the 
Imidazoles group of antibiotics, there was 100% resistance by P. aeruginosa pre-plasmid curing but 
post-plasmid curing, only methronidazole was susceptible (37.3%). However, the macrolides was 
100% resistance to it by P. aeruginosa pre and post-plasmid curing. Quinolones group of antibiotics 
were highly effective against P. aeruginosa with range from 26.7% to 80.0% pre-plasmid but range 
from 54.7% to 92% post-plasmid curing. Similarly, the cephalosprins showed susceptibility to P. 
aeruginosa with range from 17.3% to 37.3% pre-plasmid curing but 54.7% to 86.7% post-plasmid 
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curing. While the commonly used antibiotic group show low susceptibility to P. aeruginosa during 
pre-plasmid curing (5.3%) this susceptibility to P. aeruginosa was observed to increase post-plasmid 
curing with range from 16.0% to 37.3%. It was shown that post-plasmid curing raises the susceptibility 
potential to Pseudomonas aeruginosa isolates above 50% in aminoglycoside’s, quinolones’ and 
cephalosprins groups of antibiotic (see figure 1). 
 
 
 
 
 
 
 
 
Figure 1 Susceptibility to Pseudomonas aeruginosa isolates pre and post-plasmid curing to the different groups 
of antibiotics 
4. Discussion 
Pseudomonas aeruginosa is one of the most common nosocomial pathogen and the infections due to 
this organism are often difficult to treat due to antibiotic resistance. This study showed that P. 
aeruginosa is resistance to several antibiotics. In this study, 9 out of the 21 antibiotics here in studied 
presented 100% resistant to P. aeruginosa from clinical isolate. This finding showed P. aeruginosa to 
present an alarming multiple antibiotics resistivity. In accordance with this finding, resistance of P. 
aeruginosa to various antimicrobial agents has been reported by several researchers including Emori 
and Gaynes [25] and Yimaz et al [26]. 
The finding of this study showed that only Ciprofloxacin (80.0%) and Streptomycin (53.3%) 
presented susceptibility greater than 50% with Tetracycline, Cefotaxime, Ethromycin, Methronidazole, 
Nitrofuratoin, Ampicillin-clauvulanate, Ampicillin, Amoxicillin and Ampiclox presenting 100% 
resistance and others with susceptibility ranging from 5.3% to 41.3%. Taiwo et al. [27] reported P. 
aeruginosa to be sensitive in the range 70% - 94% to Ciprofloxacin and Ofloxacin and 55% - 90% to 
Gentamicin, Ceftriaxone, and Azithromycin in a study in Ilorin. Sule et al, [28] on the other hand in a 
study in Shagamu reported P. aeruginosa sensitivity in the range of 82.8% - 89.2% to 
fluoroquinolones, 61.8% - 75% to aminoglycosides and 1.7% - 46.8% to Co-trimoxazole, Ampicillin, 
and Tetracycline. Ogiwara et al. [29] in a study in Japan has reported high resistance of over 90% of 
the organisms to Tetracycline, Nalidixic acid, Nitrofurantoin, Cotrimoxazole and Ampicillin which is 
comparable to the finding in the present study. Similarly, Goniugur et al. [30] in a study in Turkey 
reported 100% resistance to Ampicillin and Penicillin and compared to our finding as well with that 
from Egypt where Elkholy et al. [31] reported a resistance of about 95% P. aeruginosa isolates to 
ABLE SUCEPTABLE RESISTANT 
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Ampicillin. 
This study showed that P. aeruginosa from clinical isolate from the study area is 100% resistant 
to multiple antibiotics (9 out of the 21 antibiotic used) and low susceptibility to many. Multiple 
antibiotics resistance, index higher than 0.2 has been said to be an indication of isolates originating 
from an environment where antibiotics were often used [32, 33]. The practical significance of the 
index may however be lost in Nigeria and other 3rd world countries where antibiotic use and abuse is 
rampant since the cutoff point was determined in countries with tight antibiotic control protocols. The 
multiple antibiotics resistance values here as reported can however be viewed as an indication of the 
extent of microbial exposure to antibiotics used within the community. 
Analysis of the resistance pattern pre-plasmid curing showed that P. aeruginosa strains from 
clinical isolate had about 42.9% multiple antibiotics resistance with only 9.5% showing susceptibility 
above 50% of the 21 antibiotic herein investigated. On the other hand, post-plasmid curing P. 
aeruginosa from clinical isolate presented about 19.1% multiple antibiotics resistance with about 
47.6% showing susceptibility above 50% of the 21 antibiotic herein investigated. The comparable 
high susceptibility post-plasmid curing over pre-plasmid curing indicates that P. aeruginosa strains 
from clinical isolate in the study area harboured plasmids and as such has developed plasmid 
mediated resistance. This is based on the fact that the high levels of resistance to antibiotics in this 
study, has been ascribed to the presence of plasmids [34-36]. 
In another line of thought, the higher susceptibility with post-plasmid curing compared to 
pre-plasmid curing showed plasmid can inhibit antibiotics activity. The findings therefore showed that 
plasmid may be involved in the high resistance to antibiotics by the P. aeruginosa strains from clinical 
isolates. This assertion is in line, considering that plasmid- mediated resistance to various 
antimicrobial drugs has been demonstrated [17, 18]. In a study at LUTH by Rotimi et al. [19], 
resistance to Gentamicin, Tobramycin and Carbenicillin were attributed to transferable plasmids. In 
another study in Greece, plasmids isolated from multi-resistant P. aeruginosa strains were found to 
encode high level resistance to Gentamicin and Tobramycin [37]. In a few cases of outbreaks in Korea, 
Japan and Turkey, plasmids encoding potent β-lactamases together with aminoglycoside-modifying 
enzymes were disseminated among P. aeruginosa strains rendering control even more difficult [8]. 
By implication, the study suggests P. aeruginosa strains from clinical isolate in the study area has 
mutated. Plasmid-mediated resistance involving modifying enzymes is particularly associated with 
topical antibiotic use and with sites where high levels of antibiotics are achieved as reported by Govan 
et al. [11]. Moreover, it is known that many antibiotic resistance genes reside in plasmids which 
facilitate there transfer [38] and thus, the suggestion that P. aeruginosa strains from clinical isolate in 
the study area may have develop a resistant gene. Acquisition of mobile genetic elements is known to 
be the main mechanism for short term accumulation of resistance determinants in bacterial genomes 
[39]. 
 
5. Conclusion 
It is clear from the results of this study that P. aeruginosa from clinical isolates in the study area has a 
very high resistance rate to most antibiotics and the commonly used antibiotics. In fact, P. aeruginosa 
presented 100% resistivity to tetracycline, Cefotaxime, Ethromycin, Methronidazole, Nitrofuratoin, 
Ampicillin-clauvulanate, Ampicillin, Amoxicillin and Ampiclox. Although there were significant 
increases in P. aeruginosa susceptibility to most antibiotics post-plasmid curing, however, Ampicillin, 
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Ampicillin-clauvulanate, Nitrofuratoin and Ethromycin were still 100% resistant to P. aeruginosa 
even after plasmid curing. The increased susceptibility to antibiotics by P. aeruginosa post-plasmid 
curing as compared to pre-plasmid curing suggests that the organism might have developed plasmid 
or a mutant. If this is the case, the reason no doubt is not far from inappropriate drug prescription and 
antibiotic misused that leads to the development and acquisition of resistance genes by bacteria. In 
this regard, health personnel needs to be aware of the prevailing antimicrobial activity pattern of at 
least, the locally available antibiotics against P. aeruginosa so as to make the right decision in the 
absence of a comprehensive antimicrobial susceptibility report. The findings of this study however 
buttress the need for proper laboratory diagnosis and susceptibility testing before antibiotic 
prescription. 
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